ImmunoINSIGHTS™, the leading antibody biomarker discovery platform to advance precision medicine.
Our Technology & Science
ImmunoINSIGHTS the analytical engine
adding insights to your clinical data
Alden Scientific Immune has developed the most advanced and comprehensive analytical platform for the discovery of Antibody / Autoantibody Biomarker Signatures. ImmunoINSIGHTS, the best-in-class biomarker discovery engine, provides access to the B cell repertoire and a pivotal class of biomarkers.
With one of the world’s largest antigen libraries covering approximately 9,000 human antigens and multi-species variants, we profile antibodies from various biologic samples in very low volume (50 µl). Developed and curated by immunologists and a team of bioinformaticians, we offer high-content biological insights and analytics powered by proprietary machine learning algorithms, models and deep knowledge mining solutions. Our platform uses Luminex xMAP® – the world’s most used multiplexing technology.
At Alden Scientific Immune, our mission is to develop innovative technologies and solutions to improve the understanding of the immune system leading to more effective, targeted and safer treatments and better diagnosis. Our scientists work hand-in-hand with our clients to discover relevant and insightful biomarkers.
Broad Expertise in Immunology
Our proprietary platform, ImmunoINSIGHTS, can be applied across different therapeutic and disease areas for a wide range of biomarker applications
Autoimmune Diseases
- Diagnostic and emerging autoantibodies, on one array
- Beyond textbook markers: sharper subgroups, earlier diagnosis
- Reads the autoantibodies that drive disease, not just flag it
- Quantifies autoantibody lowering by B-cell and autoantibody-targeting therapies
- Ties each immune profile to mechanism of action and response
Immuno-oncology
- Watch immunotherapy reshape the adaptive immune system, straight from a blood draw
- Antibodies to tumor and self-antigens in a single readout
- One accessible biomarker, measurable before, during, and after therapy
- Catch the downside early: immune-related adverse events and autoimmunity that can turn severe
- Follow response, cancer-vaccine reactions, and antibody durability over time
Infectious Diseases
- Response Prediction to Treatments & Vaccines
- Disease Severity Assessment
Neurological Diseases
- Uncover the autoimmunity behind mental and behavioral disorders
- Map the immune signature of neurodegeneration and aging
- Find the subgroups suited to B-cell or autoantibody-targeting therapy
- Link immune profiles to treatment response
Allergy / Dermatology
- Capture IgE responses and IgG/IgE autoantibodies together
- Pin down chronic spontaneous urticaria subgroups
- Identify who fits B-cell or autoantibody-targeting therapy
- Follow antibody dynamics through treatment
Multiplex Serology
- Profile a lifetime of pathogen and microbiome exposure
- Trace microbial triggers of autoimmunity, from EBV to MS
- Measure vaccine responses and how long antibodies last
- Decode the serology behind Long COVID and post-treatment Lyme
